Pathologic analysis of sentinel lymph nodes

Seminars in Surgical Oncology

Volumn 20, Issue 3, 2001, Pages 238-245

  Van Diest, Paul J ^a   Torrenga, Hans ^a   Meijer, Sybren ^a   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Fine needle aspiration biopsy; Flow cytometry; Frozen section; Immunohistochemistry; Imprint cytology; Pathology; PCR; Sentinel lymph node

Indexed keywords

EOSIN; HEMATOXYLIN;

ACCURACY; CANCER DIAGNOSIS; CANCER SCREENING; COST CONTROL; CYTOPATHOLOGY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; METASTASIS; MOLECULAR BIOLOGY; PATHOLOGY; PRIORITY JOURNAL; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SENTINEL LYMPH NODE;

BIOPSY, NEEDLE; BREAST NEOPLASMS; FEMALE; FLOW CYTOMETRY; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINES; SENTINEL LYMPH NODE BIOPSY;

EID: 0034838564     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/ssu.1039     Document Type: Review

References (87)

1. Minimal access surgery for staging of malignant melanoma
2. Sentinel lymphadenectomy for patients with clinical stage I melanoma
3. Reliability of the sentinel node procedure in melanoma patients: Analysis of failures after long-term follow-up
4. Sentinel node biopsy in melanoma patients: Dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital blue guidance
5. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy
6. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel node in vulvar cancer
7. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva
8. Sentinel node detection in cervical cancer
9. Sentinel lymph node dissection for penile cancer: The MD Anderson Cancer Center experience
10. Probe-guided surgery of colorectal carcinoma
11. Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: A case report
12. Squamous-cell carcinoma of the scrotum
13. Molecular detection of minimal residual head and neck cancer in sentinel cervical lymph nodes
14. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
15. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: Echoes from the past and the periareolar blue method
16. Sentinel lympadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
17. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
18. Less axillary node dissection necessary owing to sentinel biopsy in breast cancer patients
19. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer
20. The implementation of the sentinel node biopsy as a routine procedure for patients with breast cancer
21. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
22. Mammary lymphoscintigraphy in breast cancer
23. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes
24. Pathologic investigation of sentinel lymph nodes
25. Histopathologic workup of sentinel lymph nodes: How much is enough?
26. How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer: A short-term audit
27. The reliability of sampling three to six nodes for staging breast cancer
28. Axillary staging of breast cancer and the sentinel node
29. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
30. Immunohistochemical detection of lymph-node metastases
31. Detailed analysis of the yield from multiple level step sectioning and immunohistochemistry of the sentinel node in patients with breast cancer
32. Micrometastases from squamous cell carcinoma in neck dissection specimens
33. Primary therapy of malignant melanomas: Sentinel lymphadenectomy
34. Interoperative identification of sentinel lymph node in patients with malignant melanoma
35. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological workup
36. Effectiveness of multiple level sectioning in detecting axillary nodal micrometastasis in breast cancer: A retrospective study with immunohistochemical analysis
37. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: A preliminary study
38. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node
39. Gamma probe and ultrasonographically-guided fine-needle aspiration biopsy of sentinel lymph nodes in breast cancer patients
40. Lymphoscintigraphy and ultrasound-guided fine-needle aspiration cytology of sentinel lymph nodes in head and neck cancer patients
41. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer
42. Sentinel node localization in patients with breast cancer
43. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
44. Intraoperative examination of the sentinel lymph node for breast carcinoma staging
45. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma
46. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?
47. Frozen section analysis of sentinel lymph nodes in melanoma patients
48. Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes
49. Consequences of sentinel lymph node in clinical decision making in breast cancer and prospects for future studies
50. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
51. Protocol for ultra-rapid immunostaining of frozen sections
52. Comparison of intraoperative frozen section analysis of sentinel node with preoperative positron emission tomography in the diagnosis of axillary lymph node status in breast cancer patients
53. Pelvic lymph node metastases in prostatic carcinoma: The value of touch imprint cytology
54. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
55. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
56. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery
57. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary metastases in patients with breast cancer
58. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients
59. Flow cytometric DNA analysis combined with fine needle aspiration biopsy in the diagnosis of palpable metastases
60. Rapid peroperative assessment of axillary lymph node status using imprint cytology
61. Sentinel lymph node biopsy for the staging of breast cancer
62. Multiparameter flow cytometry (MP-FCM) as a tool for the detection of micrometastatic tumor ceils in the sentinel lymph node procedure
63. Detection of metastatic breast cancer by β-hcg polymerase chain reaction
64. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction: Comparison between MUC1 mRNA and keratin 19 mRNA amplification
65. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction
66. Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
67. RT-PCR detection of breast cancer cells in sentinel lymph nodes
68. Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction
69. Micrometastases and survival in state II colorectal cancer
70. Minimally invasive staging of patients with melanoma: Sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction
71. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients
72. Clinical relevance of molecular staging for melanoma: Comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma
73. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes
74. Lymph node micrometastases of cutaneous melanoma: Increased sensitivity of molecular diagnosis in comparison to immunohistochemistry
75. Detection of melanoma micrometastisis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin
76. Examination of regional lymph nodes by sentinel node biopsy and molecular analysis provides new staging facilities in primary cutaneous melanoma
77. Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay
78. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
79. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
80. Sentinel node biopsies in melanoma patients: A protocol for accurate, efficient, and cost-effective analysis by preselection for immunohistochemistry on the basis of Tyr-PCR
81. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR
82. Serial sectioning of sentinel nodes in patients with breast cancer: A pilot study
83. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients
84. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node
85. Detection of micrometastases in sentinel lymph nodes of the breast applying monoclonal antibodies AE1/AE3 to pancytokeratins
86. Histopathologic analysis of sentinel lymph nodes in breast carcinoma
87. High incidence of micrometastases in breast cancer sentinel nodes